Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pain × Ketamine × Clear all

Phase

Phase 3 5 Phase 4 3 Phase NA 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Head and Neck Neoplasms 1 Depressive Disorder, Major 1 Cancer Pain 1

Interventions

pegfilgrastim 1 Zoledronic Acid 1 Samarium-153 1 Samarium 1 Radiotherapy 1 Prednisone 1 Lidocaine 1 Ketamine 1 Genistein 1 Filgrastim 1 Fentanyl 1 Extracorporeal Shockwave Therapy 1 Docetaxel 1 D-methadone 1 Azacitidine 1 Antibodies, Monoclonal 1 Amantadine 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03146806 2021-09-09

Intranasal (NAS) Ketamine for Cancer Pain

Emory University

Phase 1/2 Completed

10 enrolled 26 charts

Cancer Pain, Neoplasms, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡